Overview TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris Status: Withdrawn Trial end date: 2017-02-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine the safety and effectiveness of TSN 2898 topical gel in the treatment of moderate to severe acne. Phase: Phase 2 Details Lead Sponsor: Thesan Pharmaceuticals, Inc.